Search research articles
Contact Us
Filters
Showing results (81-90 of 231) with videos related to
Page
of 24
Sort By:
Best Practice & Research. Clinical Haematology
|
May 18, 2001
Acute myeloid leukaemia (AML): treatment of the older patient
T Büchner, W Hiddemann, C Schoch, et al.
Cancer
|
July 1, 1991
Antifungal treatment by amphotericin B and 5-fluorocytosine delays the recovery of normal hematopoietic cells after intensive cytostatic therapy for acute myeloid leukemia
W Hiddemann, M E Essink, W Fegeler, et al.
Onkologie
|
August 1, 1983
[Comparison of the therapeutic efficacity of 2 induction protocols in acute myeloid leukemia using exact quantification of bone marrow cellularity]
W Hiddemann, T Büchner, M Andreeff, et al.
British Journal of Haematology
|
November 1, 1993
CD34 expression in de novo acute myeloid leukaemia
C Sperling, T Büchner, C Sauerland, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Rheumatologie
|
January 1, 1972
[Cell kinetics of chronic granulating inflammation]
T Büchner, G Junge-Hülsing, H Wagner, et al.
Klinische Padiatrie
|
May 1, 1987
[Detection of aberrations in the karyotype of children with acute leukemia: a comparative analysis of cytogenetics and flow cytophotometry]
W Hiddemann, J Harbott, H O Haas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Management of acute myeloid leukemia in elderly patients
W Hiddemann, W Kern, C Schoch, et al.
Blut
|
August 1, 1981
Intensified remission induction therapy for acute nonlymphocytic leukemia (ANLL). Treatment report on 60 patients
D Urbanitz, T Büchner, D Kamanabroo, et al.
Seminars in Oncology
|
April 1, 1992
Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia
W Hiddemann, M Kiehl, M Zühlsdorf, et al.
Onkologie
|
February 1, 1988
High-dose cytosine arabinoside and mitoxantrone: preliminary results of a pilot study with sequential application (S-HAM) indicating a high antileukemic activity in refractory acute leukemias
W Hiddemann, T Büchner, M Essink, et al.
Page
of 24
Search research articles
Search
Showing results (81-90 of 231) with videos related to
Sort By:
Page
of 24
Best Practice & Research. Clinical Haematology
|
May 18, 2001
Acute myeloid leukaemia (AML): treatment of the older patient
T Büchner, W Hiddemann, C Schoch, et al.
Cancer
|
July 1, 1991
Antifungal treatment by amphotericin B and 5-fluorocytosine delays the recovery of normal hematopoietic cells after intensive cytostatic therapy for acute myeloid leukemia
W Hiddemann, M E Essink, W Fegeler, et al.
Onkologie
|
August 1, 1983
[Comparison of the therapeutic efficacity of 2 induction protocols in acute myeloid leukemia using exact quantification of bone marrow cellularity]
W Hiddemann, T Büchner, M Andreeff, et al.
British Journal of Haematology
|
November 1, 1993
CD34 expression in de novo acute myeloid leukaemia
C Sperling, T Büchner, C Sauerland, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Rheumatologie
|
January 1, 1972
[Cell kinetics of chronic granulating inflammation]
T Büchner, G Junge-Hülsing, H Wagner, et al.
Klinische Padiatrie
|
May 1, 1987
[Detection of aberrations in the karyotype of children with acute leukemia: a comparative analysis of cytogenetics and flow cytophotometry]
W Hiddemann, J Harbott, H O Haas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Management of acute myeloid leukemia in elderly patients
W Hiddemann, W Kern, C Schoch, et al.
Blut
|
August 1, 1981
Intensified remission induction therapy for acute nonlymphocytic leukemia (ANLL). Treatment report on 60 patients
D Urbanitz, T Büchner, D Kamanabroo, et al.
Seminars in Oncology
|
April 1, 1992
Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia
W Hiddemann, M Kiehl, M Zühlsdorf, et al.
Onkologie
|
February 1, 1988
High-dose cytosine arabinoside and mitoxantrone: preliminary results of a pilot study with sequential application (S-HAM) indicating a high antileukemic activity in refractory acute leukemias
W Hiddemann, T Büchner, M Essink, et al.
Page
of 24